IAG will Present at American Society of Clinical Oncology (ASCO), May 29-31, 2020
IAG, Image Analysis Group, a strategic partner to life-sciences companies developing novel treatment, today announced that IAG’s team will present two abstracts at this year’s American Society Clinical Oncology Virtual Conference, ASCO20.
The abstracts are based upon the data from IAG’s latest clinical research studies and discuss how advanced imaging, radiomics and machine learning-augmented analysis can assist with patient phenotyping and cancer drug development.
The accepted abstracts are:
Title: “Amide proton transfer MRI can accurately stratify gliomas according to their IDH mutation and 1p/19q co-deletion status.”
Presenter: Prof. Sotirios Bisdas & Dr. Diana Dupont-Roettger
Title: “Performance of machine learning-augmented analysis of radiomics for the head and neck cancer histopathological diagnosis: A systematic review and meta-analysis.”
Presenter: Prof. Sotirios Bisdas & Dr. Diana Dupont-Roettger
Full publication released by ASCO on May 13, 2020, at 5:00 PM EST on www.abstracts.asco.org
To learn more about IAG’s work in oncology, join our scientific leadership team on a LIVE webinar: Join IAG’s scientists on a live webinar to learn more about our research efforts in Neuro-Oncology.
Send your questions to imaging.experts@localhost
Prof. Sotirios Bisdas is IAG’s Sn Director of Neuro-Oncology Research. He is a consultant neuroradiologist and MRI Lead in the Department of Neuroradiology at the National Hospital for Neurology in London, Senior Lecturer in Neuroradiology at the Institute of Neurology University College London, and Professor of Radiology at Eberhard Karls University in Tübingen, Germany. He has authored over 130 peer-reviewed publications and serves as member of the editorial board of several leading journals in Radiology and Neuroradiology. He is also reviewer for leading journals in Neuroimaging, member of the Executive Committee of the European Society of Head and Neck Radiology, and member of the Head and Neck committee of the European Society of Neuroradiology.
Dr. Diana Dupont-Roettger is Chief Scientific Alliance Officer. She is a Medical Computer Scientist by background with strong experience in novel imaging technologies and imaging markers and their role in clinical trials. She advises biopharmaceutical companies on the strategic use of advanced imaging to evaluate mechanism of action, enable precision medicine and accelerate drug development in immuno-oncology and neuro-oncology indications. Diana is actively working with biotech, pharma and investment funds helping to bridge the gap between academic research, business objectives and finances.
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: wp1.ia-grp.com
Reach out: imaging.experts@ia-grp.com
Follow the Company: Linkedin